Status:
COMPLETED
Feasibility Study to Use Biosensing Devices to Monitor PA and Resp. Function in Smokers w and w/o Resp. Symptoms/COPD
Lead Sponsor:
Kazakhstan Academy of Preventive Medicine
Collaborating Sponsors:
Philip Morris International
Synergy Research Group
Conditions:
Signs and Symptoms, Respiratory
Mobile Applications
Eligibility:
All Genders
40-59 years
Brief Summary
This study examines the feasibility and acceptability of using mobile applications and biosensing (mHealth) devices in detecting vitality parameters in current smokers with and without respiratory sym...
Detailed Description
The study is designed to investigate feasibility of using mHealth devices to improve the treatment, assessment, compliance, and outcomes in smokers with and without respiratory symptoms/COPD. The stud...
Eligibility Criteria
Inclusion
- Current smokers who are currently smoking conventional cigarettes with a minimum of 10 pack-year smoking history
- Able to use and willing to be trained to use mHealth devices
Exclusion
- COPD exacerbation that has not resolved at least 28 days prior to screening
- COPD exacerbation occurring after screening but before the first study visit
- Pneumonia or other respiratory tract infections that have not resolved at least 14 days prior to screening
- Pneumonia occurring after screening but before the first study visit
- Active respiratory disorders: tuberculosis, lung cancer, significant bronchiectasis, sarcoidosis, bronchial asthma, lung fibrosis, pulmonary hypertension, interstitial lung diseases, or other active pulmonary diseases
- Any co-morbid medical condition that in the opinion of the investigator would make participation in the study unsafe or unfeasible, including conditions that prohibit completion of exercise testing
- Use of supplemental oxygen therapy
- Inability to abstain from smoking during the period in which the participant is admitted to the Kazakhstan Academy of Preventive Medicine (KAPM) COPD Center
- A history of allergy or hypersensitivity to metal, particularly stainless steel
- Any vital sign indicator, for example, hypertension or tachycardia at rest that, at the discretion of the investigator, would make participation in the study unsafe or unfeasible
- Women who test positive for pregnancy during screening, lactating women, or women planning on becoming pregnant during the study
- Participants using assistive devices like walking aids, as these are likely to interfere with physical activity
Key Trial Info
Start Date :
June 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2019
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04081961
Start Date
June 7 2019
End Date
October 31 2019
Last Update
March 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kazakhstan Academy of Preventive Medicine
Almaty, Kazakhstan, 050008